AU620564B2 - Cholesterol reducing food containing sugar cane parenchyma cell wall - Google Patents
Cholesterol reducing food containing sugar cane parenchyma cell wall Download PDFInfo
- Publication number
- AU620564B2 AU620564B2 AU23272/88A AU2327288A AU620564B2 AU 620564 B2 AU620564 B2 AU 620564B2 AU 23272/88 A AU23272/88 A AU 23272/88A AU 2327288 A AU2327288 A AU 2327288A AU 620564 B2 AU620564 B2 AU 620564B2
- Authority
- AU
- Australia
- Prior art keywords
- international
- animals
- cell wall
- sucrafeed
- sugar cane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 title claims description 42
- 210000002421 cell wall Anatomy 0.000 title claims description 27
- 240000000111 Saccharum officinarum Species 0.000 title claims description 25
- 235000007201 Saccharum officinarum Nutrition 0.000 title claims description 23
- 235000013305 food Nutrition 0.000 title claims description 17
- 235000012000 cholesterol Nutrition 0.000 title claims description 15
- 241001465754 Metazoa Species 0.000 claims description 45
- 241000282887 Suidae Species 0.000 claims description 41
- 210000004027 cell Anatomy 0.000 claims description 24
- 241000287828 Gallus gallus Species 0.000 claims description 19
- 241000271566 Aves Species 0.000 claims description 17
- 210000000577 adipose tissue Anatomy 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 239000000463 material Substances 0.000 claims description 13
- 241000282414 Homo sapiens Species 0.000 claims description 9
- 235000000346 sugar Nutrition 0.000 claims description 9
- 241000196324 Embryophyta Species 0.000 claims description 8
- 235000013330 chicken meat Nutrition 0.000 claims description 8
- 238000011282 treatment Methods 0.000 claims description 7
- 238000004519 manufacturing process Methods 0.000 claims description 4
- 241000282412 Homo Species 0.000 claims description 3
- 241000124008 Mammalia Species 0.000 claims description 3
- 230000031018 biological processes and functions Effects 0.000 claims 1
- 230000001419 dependent effect Effects 0.000 claims 1
- 230000002906 microbiologic effect Effects 0.000 claims 1
- 230000000153 supplemental effect Effects 0.000 claims 1
- 238000002560 therapeutic procedure Methods 0.000 claims 1
- 235000005911 diet Nutrition 0.000 description 62
- 230000037213 diet Effects 0.000 description 57
- 238000002474 experimental method Methods 0.000 description 25
- 238000004458 analytical method Methods 0.000 description 9
- 210000003205 muscle Anatomy 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 8
- 235000012631 food intake Nutrition 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 7
- 235000018102 proteins Nutrition 0.000 description 7
- 108090000623 proteins and genes Proteins 0.000 description 7
- 102000004169 proteins and genes Human genes 0.000 description 7
- 210000000579 abdominal fat Anatomy 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 6
- 235000014633 carbohydrates Nutrition 0.000 description 6
- 235000013601 eggs Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 241000209140 Triticum Species 0.000 description 5
- 235000021307 Triticum Nutrition 0.000 description 5
- 230000000378 dietary effect Effects 0.000 description 5
- 235000021050 feed intake Nutrition 0.000 description 5
- 239000000835 fiber Substances 0.000 description 5
- 235000012054 meals Nutrition 0.000 description 5
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 4
- 239000003925 fat Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 235000019786 weight gain Nutrition 0.000 description 4
- 230000004584 weight gain Effects 0.000 description 4
- 241000209134 Arundinaria Species 0.000 description 3
- 235000019750 Crude protein Nutrition 0.000 description 3
- 235000019733 Fish meal Nutrition 0.000 description 3
- 244000068988 Glycine max Species 0.000 description 3
- 235000010469 Glycine max Nutrition 0.000 description 3
- 235000008429 bread Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 238000011156 evaluation Methods 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- 239000004467 fishmeal Substances 0.000 description 3
- -1 flavonoid compounds Chemical class 0.000 description 3
- 230000037406 food intake Effects 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 235000005974 protein supplement Nutrition 0.000 description 3
- 229940116540 protein supplement Drugs 0.000 description 3
- 150000008163 sugars Chemical class 0.000 description 3
- 239000001117 sulphuric acid Substances 0.000 description 3
- NGSWKAQJJWESNS-UHFFFAOYSA-N 4-coumaric acid Chemical compound OC(=O)C=CC1=CC=C(O)C=C1 NGSWKAQJJWESNS-UHFFFAOYSA-N 0.000 description 2
- 208000006758 Marek Disease Diseases 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- 230000000433 anti-nutritional effect Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 239000012141 concentrate Substances 0.000 description 2
- 235000020940 control diet Nutrition 0.000 description 2
- 235000019621 digestibility Nutrition 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 235000012041 food component Nutrition 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- 229920005610 lignin Polymers 0.000 description 2
- 150000004668 long chain fatty acids Chemical class 0.000 description 2
- 235000013372 meat Nutrition 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 229930182817 methionine Natural products 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 229940038580 oat bran Drugs 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 239000002195 soluble material Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 229940057070 sugarcane extract Drugs 0.000 description 2
- 235000011149 sulphuric acid Nutrition 0.000 description 2
- 230000036269 ulceration Effects 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 230000003442 weekly effect Effects 0.000 description 2
- NGSWKAQJJWESNS-ZZXKWVIFSA-M 4-Hydroxycinnamate Natural products OC1=CC=C(\C=C\C([O-])=O)C=C1 NGSWKAQJJWESNS-ZZXKWVIFSA-M 0.000 description 1
- IZVFFXVYBHFIHY-SKCNUYALSA-N 5alpha-cholest-7-en-3beta-ol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@@H](CC[C@@]3([C@@H]([C@H](C)CCCC(C)C)CC[C@H]33)C)C3=CC[C@H]21 IZVFFXVYBHFIHY-SKCNUYALSA-N 0.000 description 1
- DFYRUELUNQRZTB-UHFFFAOYSA-N Acetovanillone Natural products COC1=CC(C(C)=O)=CC=C1O DFYRUELUNQRZTB-UHFFFAOYSA-N 0.000 description 1
- 241000609240 Ambelania acida Species 0.000 description 1
- 239000005996 Blood meal Substances 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 239000004470 DL Methionine Substances 0.000 description 1
- IAJILQKETJEXLJ-UHFFFAOYSA-N Galacturonsaeure Natural products O=CC(O)C(O)C(O)C(O)C(O)=O IAJILQKETJEXLJ-UHFFFAOYSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 108010068370 Glutens Proteins 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 244000303512 Peucedanum ostruthium Species 0.000 description 1
- 241000255969 Pieris brassicae Species 0.000 description 1
- 244000134552 Plantago ovata Species 0.000 description 1
- 235000003421 Plantago ovata Nutrition 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 241000282849 Ruminantia Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 240000006394 Sorghum bicolor Species 0.000 description 1
- 235000011684 Sorghum saccharatum Nutrition 0.000 description 1
- 235000019755 Starter Diet Nutrition 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-WAXACMCWSA-N alpha-D-glucuronic acid Chemical compound O[C@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O AEMOLEFTQBMNLQ-WAXACMCWSA-N 0.000 description 1
- 229930014669 anthocyanidin Natural products 0.000 description 1
- 235000008758 anthocyanidins Nutrition 0.000 description 1
- 235000015241 bacon Nutrition 0.000 description 1
- 239000010905 bagasse Substances 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000003224 coccidiostatic agent Substances 0.000 description 1
- 238000004825 constant-volume calorimetry Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 230000002939 deleterious effect Effects 0.000 description 1
- 235000021004 dietary regimen Nutrition 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 239000006052 feed supplement Substances 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- NWKFECICNXDNOQ-UHFFFAOYSA-N flavylium Chemical compound C1=CC=CC=C1C1=CC=C(C=CC=C2)C2=[O+]1 NWKFECICNXDNOQ-UHFFFAOYSA-N 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- 235000010037 flour treatment agent Nutrition 0.000 description 1
- 239000012634 fragment Substances 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 230000002068 genetic effect Effects 0.000 description 1
- 235000021312 gluten Nutrition 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 244000144972 livestock Species 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- FFEARJCKVFRZRR-UHFFFAOYSA-N methionine Chemical compound CSCCC(N)C(O)=O FFEARJCKVFRZRR-UHFFFAOYSA-N 0.000 description 1
- 235000020786 mineral supplement Nutrition 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 235000003170 nutritional factors Nutrition 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid group Chemical group C(CCCCCCC\C=C/CCCCCCCC)(=O)O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 230000017448 oviposition Effects 0.000 description 1
- IPCSVZSSVZVIGE-UHFFFAOYSA-N palmitic acid group Chemical group C(CCCCCCCCCCCCCCC)(=O)O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000008442 polyphenolic compounds Chemical class 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 238000000611 regression analysis Methods 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 238000003307 slaughter Methods 0.000 description 1
- 239000006054 starter diet Substances 0.000 description 1
- 210000000352 storage cell Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 238000012956 testing procedure Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019195 vitamin supplement Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000001993 wax Substances 0.000 description 1
- 235000015099 wheat brans Nutrition 0.000 description 1
- 229940091251 zinc supplement Drugs 0.000 description 1
Landscapes
- Preparation Of Fruits And Vegetables (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Fodder In General (AREA)
Description
II I AU-AI-23272/88 PCT WORLD I LE AL PEROR IZA
S
INTERNATIONAL APPLICATION PUBLISHED UNDER THE PATENT COOPERATION TREATY (PCT) (51) International Patent Classification 4 (11) International Publication Number: WO 89/ 01295 A23K 1/14, A61K 35/78 Al (43) International Publication Date: 23 February 1989 (23.02.89) (21) International Application Number: PCT/AU88/00317 (81) Designated States: AT (European patent), AU, BE (European patent), CH (European patent), DE (Euro- (22) International Filing Date: 18 August 1988 (18.08.88) pean patent), FR (European patent), GB (European patent), IT (European patent), JP, KR, LU (European patent), NL (European patent), SE (European pa- (31) Priority Application Number: PI 3887 tent), US.
(32) Priority Date: 21 August 1987 (21.08.87) Published (33) Priority Country: AU With international search report.
(71) Applicant (for all designated States except US): FRAC- TIONATED CANE TECHNOLOGY LTD. [AU/ AUJ; GPO Box 2498, Brisbane, QLD 4001 (AU).
(72) Inventors; and A. P. 2 7 APR 1989 Inventors/Applicants (for US only) O'SULLIVAN, Mark, Humphrey [AU/AU]; 32 Lambert Road, Indooroopilly, QLD 4068 SAMPSON, Ronald,
AUSTRALIAN
Lee [US/AU]; 14 Stanmere Street, Carindale, QLD 4152 9 (74) Agent: F.B. RICE CO.; 28A Montague Street, Balmain, NSW 2041 PATENT OFFICE
-I
(54) Title: CHOLESTEROL REDUCING FOOD CONTAINING SUGAR CANE PARENCHYMA CELL WALL (57) Abstract Food for humans and other animals, particularly avian species and monogastric mammals, containing effective amounts of parenchyma cell walls from sugar cane. Such foodstuffs reduce the cholesterol and/or body fat content of the animal when the parenchyma cell wall material comprises an effective amount of the animals' diet.
j WO 89/01295 PCT/AU88/00317 CHOLESTEROL REDUCING FOOD CONTAINING SUGAR CANE PARENCHYMA CELL WALL TECHNICAL FIELD The present invention relates to a method of feeding animals, particularly monogastric animals, so as to reduce the cholesterol content thereof, and to a foodstuff for use in this method.
BACKGROUND ART It has been previously found that some complex carbohydrates derived from certain types of plant have the capacity to reduce blood cholesterol and/or body fat levels in animals including avian species and man and other mammalian species. Such complex carbohydrates have recently been obtained from oat bran and have been known for many years to be present in substantial amounts in ispaghula husks. Foodstuffs for man and other animals have been prepared which include such plant derived complex carbohydrates and have been used as part of the diet of the animal in order to reduce the cholesterol and/or the body fat content of the animal.
The known complex carbohydrates of plant origin which have been found to be able to reduce cholesterol and/or body fat levels of animals have been relatively expensive and/or difficult to obtain because of the relative scarcity of the plants or the small amount of such complex carbohydrate in the plant. The present inventors have discovered that certain parts of sugar cane plant (Saccharum officinarum) contain ingredients, probably complex carbohydrates, which are capable of reducing the cholesterol and/or body fat levels of animals consuming effective amounts of those parts of the sugar cane.
The stem or stalk of the sugar cane plant is that portion above ground which bears leaves and inflorescence. It is cylindrical in shape and is divided into joints. Each cane joint includes a node and an elongate, cylindrical, internode region. The internode WO 89/01295 PCT/AU88/00317 region comprises an outer rind made up of several layers of liguified sclerenchyma cells; and the inner pith which is made up of bundles of vascular sclerenchyma cells and the ground tissue containing parenchyma cells, which are the storage cells containing the major part of the plant juices from which sugar is recovered.
It has now been found that surprisingly the parenchyma cell wall fraction of sugar cane when fed to animals, particularly monogastric animals, produces animals having lower cholesterol levels and lower body fat levels than animals fed conventional feed rations.
DISCLOSURE OF THE INVENTION The present invention therefore comprises a method for lowering the cholesterol, and/or body fat content of animals, particularly monogastric animals, comprising the step of including in the feed rations of the animals an effective amount of parenchyma cell wall of sugar cane, preferably substantially free of fibrous sclerenchyma cells therefrom.
As used herein the expression parenchyma cells is taken to mean fresh parenchyma cell wall, dried parenchyma cell wall obtained by freeing fresh parenchyma cells from sugar cane and drying them, and dried parenchyma cells obtained by separating dried parenchyma cells or cell wall material from dried or extracted sugar cane such as bagasse. In the lattermost case sugars may be added back to the dried cell wall material to provide a sugar content at least substantially equal to that of a whole dried parenchyma cells. The parenchyma cell wall material may comprise adhered bundles of parenchyma cells or fragments of cell wall obtained by grinding or otherwise comminuting the parenchyma cells in a fresh or dried condition.
In another aspect the present invention consists in an animal feed or human food for lowering the cholesterol and/or body fat content of animals containing an effective i yy-'-PmrZ1F WO 89/01295 PCT/AI s/Nnl 7 3 amount of parenchyma cell wall of sugar cane, preferably substantially free of fibrous sclerenchyma cells therefrom. For human use foodstuffs containing from 1 to by weight of parenchyma cell wall are preferred whereas for feeding livestock, higher percentages, e.g. to 30% are preferred.
In a further aspect the present invention consists in a feedstuff comprising parenchyma cell wall material from sugar cane finely ground and sieved to remove particles larger than 100 microns.
The animal feed preferably contains additional balanced nutritional components sufficient to satisfy the dietary needs of the animal to be fed such nutritional components include vitamins, minerals and protein supplements. It is also possible that the additivies such as crude fibre may be desired to be added to the animal feed particularly if it is to be consumed by ruminant animals. In this case it may be desirable to add to the feed a proportion of the sclerenchyma cell material from sugar cane, particularly the sclerenchyma cell derived from the vascular bundles of the sugar cane.
The present invention is hereinafter described with reference to experiments conducted with pigs and chickens. It will be recognized by persons skilled in the art that this invention is not limited to the feeding of pigs and chickens but may be used to reduce cholesterol levels in other animals, and particularly avian species and monogastric mammals including man. The pig is recognised as a good model for human nutritional studies and the results obtained from studies on pigs are readily useable in assessing the utility of the present invention in humans.
BEST MODE OF CARRYING OUT THE INVENTION Hereinafter given by way of example only are preferred embodiments of the present invention.
a' WO 89/01295 PCT/AU88/00317 4- A substantially non-fibrous fraction of sugar cane, largely comprising dried parenchyma cells thereof, was prepared as described in Australian patent specification 61724/86 the contents whereof are herein incorporated by reference. This non-fibrous fraction of sugar cane is hereinafter called Sucrafeed 1 and comprises parenchyma cell walls and the dried sugar therefrom substantially free of sclerenchyma cells.
CHEMICAL ANAYLSIS Analysis of the Sucrafeed 1 yield the results set out hereunder in Tables I, II and III.
TABLE I. Major component distribution in sugar cane parenchyma cells total dry wt).
Sample Hydrophobic A HydrophilicE Cell wallsC material material 1 1.1 63.2 35.7 2 1.0 66.3 32.7 A. chloroform-soluble material, e.g. lipids, pigments, waxes, etc.
B. 80% ethanol-soluble material, e.g. free sugars, free phenolics, etc.
C. 80% ethanol-insoluble material, e.g. polysaccharides, lignin.
Note: B is considered highly digestible and the components are not bound to cell-wall polymers.
(ii) There should be very little protein in the sample (cell wall).
(iii) The total analytical procedure was performed in duplicate (samples 1 and 2).
WO 89/01295 PCT/AU88/00317 TABLE II. Components in 80% ethanol-soluble fraction (B in Table I) as fraction.
Sample Total freea Total freeb Unaccounted forc phenolics sugars material 1 1.4 54.9 43.7 2 1.2 53.0 45.8 aby Folin-Ciocalteu reagent against p-coumaric acid standard.
bby phenol-sulphuric acid against D-glucose standard.
Cby difference (pigments, flavonoids).
Note: Sample aliquot with cone. sulphuric acid gave a noticeable pink colour indicative of flavonoid compounds, e.g. anthocyanidins.
TABLE III. Composition of sugar cane parenchyma cell-wall fraction (C in Table I) as fraction.
Sample Neutral sugarsa Uronicb Apparentc Unaccountedd Ara Xyl Glc acids lignin for material 1 3.1 19.9 33.2 3.0 24.2 16.6 2 3.2 20.1 33.5 3.1 27.8 12.3 aby g.l.c. of alditol acetates; trace amounts of mannose, galactose.
bby 3-pehnylphenol method against D-glucuronic acid standard.
cthis will include minerals insoluble in 72% sulphuric acid (ash).
dby difference polyphenols soluble in acid and experimental error associated with methodology).
WO 89/01295 PCT/AU88/00317 EVALUATION OF ANIMAL FEED PIGS The evaluation of Sucrafeed 1 as a dietary energy source for pigs consisted of two separate experiments.
Firstly, the digestible energy content of the sugar cane extract was determined in 4 individually-fed pigs (approximately 30 kg liveweight).
Secondly, diets were formulated incorporating 0, 15 or of Sucrafeed 1 in the diet. The diets were formulated to meet the needs of the growing/finishing pig using the digestible energy value of the extract obtained from the first experiment. Each diet was pelleted and fed to a total of 30 pigs .(male and female) maintained under commercial piggery conditions (3 pens each containing pigs).
EXPERIMENTAL DETAILS EXPERIMENT 1 Determination of the digestible energy content.
Four pigs (30 kg liveweight) were maintained in individual metabolism cages and fed Sucrafeed 1 ad libitum for a 4 day preliminary period. Faecal output and feed intake of the pigs was subsequently measured over a 3 day period. The gross energy content of the feed and faeces was determined by bomb calorimetry and the digestible energy (DE) content of the diet was calculated.
EXPERIMENT 2 Determination of the food intake and growth of pigs.
Diets Diets were formulated at The University of Queensland and prepared by Cheethams Feed Pty. Ltd., Wacol, Brisbane, Australia, to meet the standard requirements of the growing/finishing pig (Table IV).
After mixing the ingredients the diets were pelletized.
WO 89/01295 PCT/AU88/00317 TABLE IV. Composition and analysis of diets.
Level of Feed Supplement According to this Invention Ingredients 0 15 Sucrafeed 1 0 15 Wheat 83.7 63.6 42.8 Soya 6.2 10.5 15.0 Meatmeal 2.0 2.0 Bloodmeal 2.0 2.0 Fishmeal 5.0 5.0 Tallow -0.8 2.1 DL methionine 0.6 0.6 0.6 Sale 0.25 0.25 0.25 Premix (Vit/Min) 0.15 0.15 0.15 Copper/Zinc supplement 0.1.0 0.10 0.10 Analyses Digestible energy (MJ/kg DM) 13.4 13.4 13.4 Crude protein 17.0 17.0 17.0 Fibre 3.0 7.2 12.0 Animals A total of 9'0 Large White x Yorkshire pigs (36 females and 54 males) were used in the experiment. A comparison of the growth of 10 pigs fed diets containing either 0, 15 or 30% Sucrafeed 1 was temporally replicated, using in total 30 pigs (3 pens of 10 pigs), on each dietary treatment.
The mean starting weight of pigs in the experiment was 30 kg and the animals were slaughtered when they reached 80 kg. Slaughtering was conducted at Queensland Bacon Abattoir, Murarrie, after an overnight fast.
Backfat thickness was measured by the Abattoir on each animal and random carcasses were sectioned to measure eye muscle area and to obtain fat samples for cholesterol and long chain fatty acid (LCFA) analysis.
WO 89/01295 PCT/AU88/00317 RESULTS AND DISCUSSION EXPERIMENT 1. The mean digestible energy content of the diet was found to be 11.5 0.2 MJ DE/kg DM in the four pigs. Given the gross energy of the diets (16.7 MJ GE/kg DM), the apparent energy digestibility was 0.69 From these results it can be calculaed that approximately 30% of the fibre in the extract must have been digested by the pigs, presumably in the large intestine.
EXPERIMENT 2. After 3 weeks of the experiment, one pig fed the control diet Sucrafeed 1) died of gastric 11ceration, otherwise there were no signs of disease or adverse nutritional factors. Such gastric ulcerations are observed regularly in pigs fed, conventional pig diets.
Thus it is of interest that no cases of ulceration were observed in the pigs fed diets containing 15 or Sucrafeed 1.
There were no signiticant differences in feed intake, liveweight gain and theiefore feed conversion efficiency of the pigs fed the three dietary regimens (Table The liveweight gains are comparable with superior industry levels of 700-800 g/day for pigs of the same weight range. These results indicate that the diets containing Sucrafeed 1 were' highly acceptable to the pigs, had no deleterious effects and resulted in substantial liveweight gains.
TABLE V. Growth performance of pigs fed diets containing 0, 15 or 30% Sucrafeed 1.
Level of Sucrafeed 1 in diet(%) SEM Parameter 0 15 Liveweight gain 802 797 790 9.00 Feed intake (kg/d) 2.33 2.31 2.36 .03 Feed conversion* 2.91 2.90 2.94 .01 Kg feed/kg liveweight gain.
_I_
WO 89/01295 PCT/AU88/00317 9 The carcass characteristics of pigs fed the dietary treatments are presented in Table VI. There was a small (non-significant) reduction in the dressing percentage of the carcasses of pigs fed Sucrafeed. This was due to the higher levels of fibre in the diet of the pigs fed Sucrafeed 1, resulting in a greater weight of the gastrointestinal tract.
TABLE VI. Carcass characteristics of pigs fed diets containing varying levels of Sucrafeed 1.
Level of Sucrafeed 1 in diet(%) SEM Parameter 0 15 Dressing percentage 75.1 74.1 Backfat thickness (mm) 17.9 16.5 Eye muscle area (cm 2 47.8 48.0 54.2 Proportion of individual fatty acids in Myristic 2.2 2.8 Palmitic 24.6 21.8 Palmitoleic 2.1 2.2 Stearic 13.9 12.1 Oleic 45.2 48.2 Linoleic 11.9 12.7 Cholesterol 94.5 78.7 (mg/100g fatty tissue) 73.1 14.8 2.30 backfat 2.9 24.9 2.5 14.8 43.1 11.9 61.7 0.35 0.25 0.36 1.32 0.42 0.31 2.00 0.32 14.6 Backfat Sucrafeed 1, pigs fed 30% thickness was significantly less in pigs fed the lowest thickness being recorded for the of Sucrafeed 1 (Table VI). The eye muscle area of only 5 pigs on each treatment were measured.
Nevertheless, there was a significant linear relationship between level of Sucrafeed 1 and eye muscle area.
Although the muscle of pigs contains relatively low levels of fat (due to the lack of marbling as seen in beef), the lower amount of backfat thickness and the greater eye muscle area are significant findings and should be
I
WO 89/01295 PCT/AU88/00317 exploitable as selling points. The pig industry is attempting to reduce the fat cover of pigs and increase eye muscle, both by nutritional and genetic means, Sucrafeed 1 can be utilised on this basis as a valuable feed ingredient.
Cholesterol levels in the fatty tissues were measured in 15 pigs only. There are obvious and exciting differences in the mean values and there is a substantial reduction in the cholesterol levels as the level of Sucrafeed 1 was increased from 0 to 15% to There was no change in the fatty acid composition of the depot fats in the pigs.
SUMMARY
1. The digestible energy content for growing pigs of Sucrafeed 1 was found to be 11.5 0.2 MJ DE/kg DM. The digestibility of the extract was 0.69 2. Diets containing up to 30% of the Sucrafeed 1 can be easily pelletized and are very acceptable to young pigs.
3. The sugar cane extract does not appear to contain any anti-nutritive factors which alter feed intake, growth or any other aspect of performance.
4. Although the fibre content of the experimental diet containing 30% of the extract was higher than considered optimal for growing pigs, the substitution of 30% of Sucrafeed 1 had no adverse effects on food intake and growth rate.
The highest rate of Sucrafeed 1 inclusion resulted in significantly less backfat than the controls inclusion). There was a significant positive relationship between the dietary level of Sucrafeed 1 and eye muscle area; when more Sucrafeed 1 was fed the eye muscle area was greater. These two results highlight the positive benefits of including Sucrafeed 1 in diets for pigs.
6. There were marked differences in cholesterol levels WO 89/01295 PCT/AU88/003.17 11 in the fatty tissues.
7. The fatty acid composition of the backfat of the pigs was not affected by including Sucrafeed I in the diets.
EVALUATION OF ANIMAL FEED CHICKENS Four experiments with chickens were conducted.
Experiments 3 and 4 were conducted between October and December 1986 at the University of Queensland's Veterinary Science Farm at Pinjarra Hills. Experiment 3 was a growth trial undertaken using meat-type chickens from four to eight weeks of age. Experiment 4 was undertaken using adult cockerels to determine metabolising energy of SucrAfeed 1 and of prepared diets. Experiments 5 and 6 were undertaken at the University of New England in Armidale. Experiment 5 was a growth trial undertaken using 6 week old crossbred cockerels and Experiment 6 was an egg laying trial undertaken using old hens and pullets.
EXPERIMENTAL DETAILS EXPERIMENT 3 Diets Four diets were formulated to contain 0, 10, 20 and of Sucrafeed 1 on an iso-energetic and iso-nitrogenous basis. An attempt was also made to obtain similar essential amino acid profiles.
Significant compensation was required for the low protein level in Sucrafeed 1 (approximately This meant an increase in protein supplements such as soyabean meal and fishmeal. Further, because of the lower ME value of Sucrafeed 1 than of the grains used, and because of the need for increased inclusion of low energy protein supplements, it was necessary to add extra oil to diets containing Sucrafeed 1 to adjust the ME value.
the diets are shown in Table IV. Because of the low density of Sucrafeed 1 and the problems experienced in the ME study, diets B, C and D were pelleted.
I II- WO 89/01295 PCT/AU88/00317 12 Experimental Birds Chickens from two lines selected for five generations for either high or low abdominal fat were used in the study. The lines were originally derived from a commercial broiler line. Birds were individually identified with wingbands.
TABLE VII. Composition and analysis of diets given to chickens in the growth experiment from 4 to 8 weeks of age.
Ingredient Inclusion level (g/kg) diet A B C D Wheat 500 395 295 170 Sorghum 180 150 100 Sucrafeed 1 100 200 300 Meat meal 100 100 100 100 Soyabean meal 145 160 180 200 Fishmeal 30 40 50 Oil 30 40 60 Methionine 1.5 1.4 1.4 1.3 Salt 2.5 2.5 2.5 Vit./min. premix 3.0 3.0 3.0 Celite 8.5 8.5 8.5 Coccidiostat 1.0 1.0 1.0 Analysis ME* MJ/kg 13.3 13.1 12.9 13.0 ME** MJ/kg 12.8 13.1 13.5 13.2 C* Protein 21.5 21.5 21.5 21.3 Protein 23.3 23.1 23.8 24.1 Calculated Analysed The birds were reared in intermingled groups to 4 weeks of age in battery brooders and were given a typical commercial broiler starter diet containing 13.0 MJ ME and 230g crude protein (CP)/kg. The diet was in mash form.
WO 89/01295 PCT/AU88/00317 13 Experimental Cages and Management At four weeks of age the birds were transferred to individual cages each with a separate feeder. Twenty birds from each line were given one of the four diets and allowed food ad lib for the 28 day experimental period.
Birds were individually weighed at 4 and at 8 weeks of age when the experiment was terminated. Individual food consumption over the period was measured and food conversion efficiency was calculated. Following overnight withdrawal of feed, the birds were processed and abdominal fat was removed and weighed.
Results Growth, Food Intake and Food Conversion Efficiency TABLE VIII. The effect of diet upon weight gain, food consumption and food conversion efficiency.
Least square means Standard err.o Diet Weight gain Food Consumption Food conversion ratio
(FCR)
A 982 21 2378 39 2.44 .03 B 991 20 2370 37 2.41 .03 C 974 20 2370 37 2.45 .02 D 979 20 2385 38 2.46 .03 As shown in Table VIII, there was no effect of diet upon weight gain, food consumption or FCR. In fact, the means are remarkably similar indicating that provided energy and protein are adjusted to compensate for the values in Sucrafeed 1, there are no antinutritional factors in this material which would prevent its inclusion in meat chicken diets up to 30% of the diet.
Abdominal Fat The result of the abdominal fat measurements are shown in Table IX. There was a lower level of abdominal fat in the chickens fed Sucrafeed 1. This was significant at the 90% level using an orthogonal contrast method of analysis.
-ra l WO 89/01295 PCT/AU88/00317 14 TABLE IX. The effect of diet, upon the proportion of abdominal at in the carcasses of birds given diets containing different levels of Sucrafeed 1.
Least square means Standard error Diet Abdominal fat (g/kg) A 24.1 1.3 B 21.9 1.2 C 20.8 1.2 D 22.0 1.2 EXPERIMENT 4 Adult cockerels were used to determine ME in the four diets used in the growth experiment. The study was undertaken to firstly determine ME of the four diets and secondly to provide an estimate of the ME of Sucrafeed 1.
The latter estimate was unlikely to be precise since there were a number of differences in ingredient composition between the diets.
Twelve adult cockerels were used, with each diet allocated to three cockerels. The testing procedures used in the first ME study were again applied in this experiment.
Results ME's calculated in the four diets were: A 12.8; B 13.1; C 13.5 and D 13.2.
As shown in Table VII, these values are in reasonable agreement with the estimated values assuming a value of 9.0 MJ/kg for Sucrafeed 1. However, whilst not conforming to a close linear fit, there is a tendency for the diets containing higher levels of Sucrafeed 1 to have higher ME. Using regression analysis this yields an estimate of ME for Sucrafeed 1 of 11.5 MJ/kg, a value in keeping with data being collected from other species.
r jj j jjj j jj j jjjjk WO 89/01295 15 PCT/AU88/90317 In conclusion it is important to note, as shown in Table VIII, there was no difference in the growth rate, or food conversion efficiency or food consumption of the birds on the different diets containing various amounts of Sucrafeed 1.
EXPERIMENT Birds Diets Time Recordings TABLE X. Bo Sucrafeed fed to crossbred cockerels 6 weeks old crossbred cockerels 850 gm 4 birds per cage, 3 cages per treatment a) Control complete b) Choice fed protein concentrate plus Sucrafeed 1 separate containers 3 periods of 1 week each a) Weekly body weight increases b) Weekly feed intakes dy weight gain in grams Week 1 2 3 Sucrafeed 1 Replicate Control Replicate 1 2 3 Average 1 2 3 Average 524 415 480 473 670 701 688 686 998 884 794 794 895 668 688 750 688 761 693 714 755 405* 919 693 One bird sick with Marek's disease.
Elk -a WO 89/01295 TABLE XI. Food conversion.
PCT/AU88/00317 16 Week 1 2 3 Sucrafeed 1 Replicate Control Replicate 5.6 6.75 5.91 3.66 3.49 3.59 3.54 3.91 3.82 3.44 4.59 4.75 5.35 4 .77 4.67 4.05 7.12* 3.44 One bird sick with Marek's Disease.
TABLE XII. Final weights.
Bodyweight (Kg) Fat Pad (gm) Sucrafeed 1 Replicate Control Replicate 1.423 1.360 1.300 1.520 1.240 1.431 4.9 5.7 3.7 11.8 13.0 13.3 It can be seen that the birds fed Sucrafeed 1 had significantly lower fat pad weights than the birds fed the control diet.
EXPERIMENT 6 LAYING TRIALS 1. Old Hens choice fed protein concentrate and whole wheat or Sucrafeed 1 with 3 hens per treatment.
Results were as shown in Table XIII.
1 I 11 WO 89/01295 PC/AU88/00317 17 Q TABLE XIII Egg production Diet July August September Total Wheat 1 19 26 14 ;o Sucrafeed 1 2. Pullets same diets 4 pullets per treatment.
Results were as shown in Table XIV.
TABLE XIV Egg production Diet July August September Total Wheat 1 0 2 20 22 2 10 28 26 64 3 18 28 28 64 4 11 30 22 63 Sucrafeed 1 1 11 27 29 67 2 10 27 30 64 3 11 23 30 64 4 11 30 28 69 The lipid and cholesterol content of the pullet eggs were determined and the results were as indicated in Table XV.
i i i WO 89/01295 S18 TABLE XV. Analysis of pullet eggs.
PCT/AU88/00317 Wheat diet Sucrafeed 1 Diet
LIPIDS
Aug. 87 Sept. 87 Oct. 87 Nov. 87 9.3% 10.7% 10.3% 10.2% 8.2% 9.6% 10.1% 9.8% CHOLESTEROL (total egg) Aug. 87 401 MG/100g Sept. 87 496 MG/100g 369 MG/100g 436 MG/100g It can be seen that egg production was increased with the hens and pullets fed Sucrafeed 1 and that the lipid and cholesterol contents of the eggs produced by these birds were lower.
I -IIUY-I~-.II--C' i i WO 89/01295 PCT/AU88/00317 -19 PREPARATION OF HUMAN FOODSTUFFS Bread was prepared for human consumption using the ingredient as TABLE XVI shown in Table XVI.
1.
Standard Cereal (g) 2.
2% Cane Flour+ Oat Bran (g) 3.
4% Cane Flour+ Oat Bran (9) 4.
Standard 90/10 Meal (g) 2% Cane Flour+ 90/10 Meal (g) B.B. Flour Oat Bran Wheat Bran Granary Salt Caster Sugar "Cane Flour" Gluten BFIO Bread Improver MM Shortening 667.2 100.1 59.3 26.7 16.7 16.7 13.3 11.3 8.0 667.2 100.1 59.3 26.7 16.7 16.7 13.3 11.3 8.0 667.2 100.1 59.3 26.7 16.7 33.4 13.3 11.3 8.0 735.8 117.7 16.9 8.8 11.8 8.8 735.8 117.7 16.9 18.0 8.8 11.8 8.8 Total 919.3 919.3 936.0 899.8 917.8 Yeast Water Mixing Time Mixing Temp.
In Proover Out Proover 36.0 520.0 7.5 30.0 9.00 10.05 36.0 520.0 7.25 30.5 9.35 10.35 60.0 breads mixed 36.0 530.0 7.75 31.0 10.16 11.23 67.0 like a 36.0 36.0 580.0 590.0 9.0 31.0 30.0 10.55 11.35 12.00 12.32 65.0 57.0 standard bread to above is the Proof Time(min) 65.0 All of the above and rose well. The "cane flour" referred Sucrafeed 1 material finely groun" and passed through a 100 micron sieve.
4 ,w
I!.
Claims (9)
1. A method for lowering the cholesterol and/or body fat content of animals comprising the step of feeding to the animals an effective amount of parenchyma cell wall of sugar cane.
2. A method as claimed in claim 1 in which the feed rations of the animals are substantially free of fibrous sclerenchyma cells derived from sugar cane.
3. A method as claimed in claim 1 in which the feed rations of the animals contain parenchyma cell walls of sugar cane together with an amount of free sugar at least equal to that naturally present in the parenchyma cells from which the cell wall is obtained.
4. A method as claimed in claim 3 in which the feed ration of the animal contains dried whole parenchyma cells together with the dried natural contents of those cells.
A method as claimed in claim 1 in which the parenchyma cell wall material constitutes from 1 to 30% by weight of the feed ration.
6. A method as claimed in claim 1 in which the animals are selected from'the group comprising avian species and monogastric mammals.
7. A method as claimed in claim 6 in which the animals are selected from the group comprising humans, pigs and chickens.
An animal food forL lowerin M cth l body fat levels of animals containing an effecti eamount of parenchyma cell wall of sugar cane.
9. An animal food as claimed in clj- 8 in which the animal food is substantially fr of fibrous sclerenchyma cells from sugar cane. An animal food claimed in claim 8 in which the animal food co tains parenchyma cell wall together with an amount of ree sugar at least equal to that naturally pmrent in the parenchyma cells from which the cell wall INTERNATIONAL SEARCH REPORT International Application No PCT/AU 88/00317 1. CLASSIFICATION OF SUBJECT MATTER (it several clossirication symbolit apply. indicate all) According to International Patent Claosilfceilon (IPC) or to both National Classincation and WPC Int. Cl. 4 A23K 1/14, A61K 35/78 1I, FIELDS SEAPCHED Minimum Documentation SearchedI Classification System jClaslficaton Symbols IPC A23K 1/14 Documentation Saerched other than Minimum Documentation to the Extent that such Documents are included In the Flelds SearchedI AU IPC as above, Australian Classification 87.11 Ill. DOCUMENTS CONSIDERED TO ME RELEVANT' Category C~tatIon of Document."1 witht IndIcation. where appropriate. of the relevant Uasg.' Relevant to Claim No. $31 X,Y AU,B, 61724/86 (568460) (O'SULLIVAN, (8-14) March 1987 (05.03.87) A AU,B. 46077/72 (472893) (YOSIAKI KIMURA) (8-14) 7 March 1974 (07.03.74) A AU,B, 20637/56 (217107) (TEMPLE, WIGGINS, (8-14) 14 February 1957 (14.02.57) A,Y GB,A;329766 (CANADIAN CANE EQUIPMENT LTD) (8-14) I 12 September 1973 (12.09.73) Spectal categorles of cited documents: 14 -T later document publish"d after the International filing date docuentdefiingthe eneal tate.4 he at w~ch s nt o priority date end not In conflIct with the applicatloo; but ocuentd~flj" he eneal sateof he rt wichle ot cited to understand the principle or theory underiylntV the considered to be of particular relevance Invention 11 rlldc&c ut ublishhed on of:tlteitralni X* oueto at.ua olvn the cladInvet rvk scfo o eason th uiaindt faohr *1dcmn fpriua ~os the claimed Invention dewe efr~ oal e dIsclosure. use, eshitton or document Is combined with one or more other such docu. 's ourvpulse t to the International filing dale but In the art.ovost Lesns~e Dateof te AtualComlailn oftheIntenatonalSeach Dis o Malingof his nta Searchll$* Reportor 2 NovembLer 1988 (02.11.88) 24 Noverobc-( lq156(24JI b.) AutainPatent Office J.P. PLIET Farm PCTIISA12I0 (second sheet) (January, 1965 I I inlrnational Applicatidn No. PCT/AU 8/00317 FURTHER INFORMATION CONTINUED FROM THE SECOND SHEET I VQ~ OBSERVATIONS WHERE CERTAIN CLAIMS WERE FOUND UNSEARCHABLE I This International search report has not been established in respect Of certain claims 'inder Article 27Cn for the following reasons-. I Claim numbers1.-Z7i1 5 because they relate to subject matter not required to be searched by this Authority, namely: 1-7. Methods for treatment of the human or animal body by therapy. Plant or animal varieties, or essentially biological processes for the production of plants or animals, other than microbiological processes and the products of such processes. because they reid.e to parts of the International application that do not comply with the pescribed require- ments to such an extent that no meanngful international search can be Qarrikd out. specficaly: 3E] Claim numnberz_..... beause uny wre dependent cialm n r not drafted In bo dance With the second and ti*d SOntM ce M o PCT Rule 6.4(s). VLQ ONSERVATIONS WHERE UNITY OF INVENTION IS LACKING I Tis Internalional Searching Authority found multiple Inventions In tWte International application as Wolows: 141Ac aNl required additional search fees were timely pa&d by the appicant. this international search report covers all searchable clms of the International application. As only come of the required additional search fees were timely peid by the applicant, this Interailonal search report covers only those claim@ of the international application for which fees were paid. specifically claims: 3.oH required additional search fees were timely paid by the applicant. Consquentily. this International search report Is restricied to the Invention first mentioned In the claims. It is covered by claim numbers: As all searchable claims could be searched without sffort Jusifying an additionul fee, the International Searching Authority did not invit payment of any additional lee. Remert on Protest fl The additional search lees were accompanied by aplicant's protest. QC No protest accompanied the psyment of additional &earch lees. Form PCT11SA1210 (supplemental sheet 1.1snuary 1965) i ANNEX TO THE INTERNATIONAL SEARCH REPORT ON INTERNATIONAL APPLICATION NO. PCT/AU 88/00317 This Annex lists the known publication level patent family members relating to the patent documents cited in the above-mentioned international search report. The Australian Patent Office is in no way liable for these particulars which are merely given for the purpose of information. Patent Document Cited in Search Patent Family Members Report AU 61724/86 BR 8604189 CN 86106230 EP 213605 JP 62083851 ZA 8606468 AR 202087 AU 46077/72 BR 7205943 DE 2242410 DK 4062/79 GB 1395311 IT 986019 JP 48032653 NL 7211834 JP 48032654 PH 11918 US 4011806 JP 4803:655 FR 2150948 JP 48032658 ZA 7205819 JP 48032656 US 3903307 GB 1329766 CA 1021624 US 3721567 US 3796809 END OF ANNEX *23/135/1
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU23272/88A AU620564B2 (en) | 1987-08-21 | 1988-08-18 | Cholesterol reducing food containing sugar cane parenchyma cell wall |
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AUPI3887 | 1987-08-21 | ||
| AUPI388787 | 1987-08-21 | ||
| AU23272/88A AU620564B2 (en) | 1987-08-21 | 1988-08-18 | Cholesterol reducing food containing sugar cane parenchyma cell wall |
| PCT/AU1988/000317 WO1989001295A1 (en) | 1987-08-21 | 1988-08-18 | Cholesterol reducing food containing sugar cane parenchyma cell wall |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2327288A AU2327288A (en) | 1989-03-09 |
| AU620564B2 true AU620564B2 (en) | 1992-02-20 |
Family
ID=31891619
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU23272/88A Expired AU620564B2 (en) | 1987-08-21 | 1988-08-18 | Cholesterol reducing food containing sugar cane parenchyma cell wall |
Country Status (1)
| Country | Link |
|---|---|
| AU (1) | AU620564B2 (en) |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1329766A (en) * | 1970-04-08 | 1973-09-12 | Canadian Cane Equip | Production of livestock feed from sugarcane |
| AU4607772A (en) * | 1971-08-30 | 1974-03-07 | Yosiakikimura | Process of making feedstuff containing bagasse protein, and yeast and apparatus therefor |
| AU6172486A (en) * | 1985-09-02 | 1987-03-05 | Mark Humphrey O'sullivan | Disintegrating sugar cane |
-
1988
- 1988-08-18 AU AU23272/88A patent/AU620564B2/en not_active Expired
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1329766A (en) * | 1970-04-08 | 1973-09-12 | Canadian Cane Equip | Production of livestock feed from sugarcane |
| AU4607772A (en) * | 1971-08-30 | 1974-03-07 | Yosiakikimura | Process of making feedstuff containing bagasse protein, and yeast and apparatus therefor |
| AU6172486A (en) * | 1985-09-02 | 1987-03-05 | Mark Humphrey O'sullivan | Disintegrating sugar cane |
Also Published As
| Publication number | Publication date |
|---|---|
| AU2327288A (en) | 1989-03-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1130976B1 (en) | Method of reducing cholesterol in animal products | |
| Joysowal et al. | Effect of Azolla (Azolla pinnata) feed on the growth of broiler chicken | |
| Nikolaev et al. | Poultry Product Manufacturing Using By-Products of Fat-and-Oil Industry | |
| Bindelle et al. | Voluntary intake, chemical composition and in vitro digestibility of fresh forages fed to Guinea pigs in periurban rearing systems of Kinshasa (Democratic Republic of Congo) | |
| Maisonnier et al. | Analysis of variability in nutrient digestibilities in broiler chickens | |
| WO1989001295A1 (en) | Cholesterol reducing food containing sugar cane parenchyma cell wall | |
| Heuser | Feeding poultry | |
| Emiola et al. | Performance and organ weights of laying hens fed diets containing graded levels of sun-dried cocoa bean shell (CBS) | |
| Isikwenu et al. | Haematological response, performance and economic analysis of cockerel chicks fed enzyme supplemented brewer’s dried grains groundnut cake-based diets | |
| AU620564B2 (en) | Cholesterol reducing food containing sugar cane parenchyma cell wall | |
| Aderemi et al. | Evaluation of fermented Locust Bean Meal (Parkia biglobosa) as a replacement to soybean meal on production performance, blood profile and gut morphology of broiler chicken | |
| Cufadar et al. | Effects of xylanase enzyme supplementation to corn/wheat-based diets on performance and egg quality in laying hens | |
| Suga et al. | Application of cellulolytic and plant tissue macerating enzyme of Irpex lacteus Fr. as feed additive enzyme | |
| Mandey et al. | Effect of dried rumen content with and without cellulase in diet on carcass quality of broiler chickens | |
| Altwoate et al. | Utilizing Date Seed Waste Meal as an Alternative Feed for Pullets | |
| Archibong et al. | Response of broiler chickens to sand box seed meal based-diets supplemented with or without enzyme | |
| Adeniji | Effects of dietary grit inclusion on the utilization of palm kernel cake by pullet chicks | |
| Fatima et al. | Impacts of feeding graded levels of baobab seed meal instead of concentrate on growth performance and feed utilization of broiler chicks | |
| Esiegwu et al. | Growth performance and blood indices of broiler finisher birds fed enzyme-fortified (Maxi grain) rice milling waste. | |
| Darkwa et al. | Responses of growing rats and pigs to diets containing varying levels of dried brewers’ spent grains supplemented with Bergazym-an exogenous enzyme complex | |
| Darwazeh | Effects of rumen filterate fermented wheat bran on performance of finishing broiler chickens | |
| Savón et al. | Use of Tithonia diversifolia in non-ruminants | |
| Emam | EFFECT OF INCLUSION OF SUGAR BEET PULP IN THE DIETS ON THE PERFORMANCE OF BROILER CHICKENS | |
| Kiiskinen et al. | The incidence of tibial dyschondroplasia in two broiler strains and their performance on different diets | |
| Stevenson | Effect of added cassava root meal, ZnO and their interaction on the production and quality of eggs from laying hens |